Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics

Nat Biotechnol. 2017 Jun 7;35(6):500-502. doi: 10.1038/nbt.3882.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Line, Tumor / drug effects
  • Dose-Response Relationship, Drug*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Pharmacogenetics*